273 related articles for article (PubMed ID: 7851481)
1. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.
Liu JT; Paul W; Emerson M; Cicala C; Page CP
Eur J Pharmacol; 1994 Oct; 264(2):183-90. PubMed ID: 7851481
[TBL] [Abstract][Full Text] [Related]
2. The pharmacological modulation of thrombin-induced cerebral thromboembolism in the rabbit.
May GR; Paul W; Crook P; Butler KD; Page CP
Br J Pharmacol; 1992 May; 106(1):133-8. PubMed ID: 1504722
[TBL] [Abstract][Full Text] [Related]
3. The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis.
Elg M; Gustafsson D; Deinum J
Thromb Haemost; 1997 Oct; 78(4):1286-92. PubMed ID: 9364999
[TBL] [Abstract][Full Text] [Related]
4. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
[TBL] [Abstract][Full Text] [Related]
5. Modulating platelet function with selective thrombin inhibitors.
Verstraete M
Haemostasis; 1996 Oct; 26 Suppl 4():70-7. PubMed ID: 8979113
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ
Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674
[TBL] [Abstract][Full Text] [Related]
7. [Direct thrombin antagonists].
Lankes W; Fleischer K; Gulba DC
Herz; 2001 Apr; 26 Suppl 1():46-52. PubMed ID: 11349627
[TBL] [Abstract][Full Text] [Related]
8. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
[TBL] [Abstract][Full Text] [Related]
9. The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits.
Paul W; Gresele P; Momi S; Bianchi G; Page CP
Br J Pharmacol; 1993 Dec; 110(4):1565-71. PubMed ID: 8306102
[TBL] [Abstract][Full Text] [Related]
10. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
[TBL] [Abstract][Full Text] [Related]
11. Effective use of BCH-2763, a new potent injectable direct thrombin inhibitor, in combination with tissue plasminogen activator (tPA) in a rat arterial thrombolysis model.
Deschênes I; Finkle CD; Winocour PD
Thromb Haemost; 1998 Jul; 80(1):186-91. PubMed ID: 9684808
[TBL] [Abstract][Full Text] [Related]
12. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
[TBL] [Abstract][Full Text] [Related]
13. Characterization of in vitro and in vivo platelet responses to thrombin and thrombin receptor-activating peptides in guinea pigs.
Chiu PJ; Tetzloff GG; Foster C; Chintala M; Sybertz EJ
Eur J Pharmacol; 1997 Feb; 321(1):129-35. PubMed ID: 9083795
[TBL] [Abstract][Full Text] [Related]
14. Effect of thrombin inhibitors on platelet functions: comparative analysis of DuP 714 and hirudin.
Reilly TM; Knabb RM; Hassell SM; Bozarth JM; Forsythe MS; Mayo MC; Racanelli AL; Mousa SA
Blood Coagul Fibrinolysis; 1992 Oct; 3(5):513-7. PubMed ID: 1450317
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials of conjunctive anticoagulant strategies in thrombolysis.
Kleiman NS
Coron Artery Dis; 1996 Jul; 7(7):508-15. PubMed ID: 8913678
[No Abstract] [Full Text] [Related]
16. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
17. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
[TBL] [Abstract][Full Text] [Related]
18. Thrombin inhibitors and cardiopulmonary bypass.
Merry A
J Extra Corpor Technol; 2006 Mar; 38(1):52-6. PubMed ID: 16637526
[No Abstract] [Full Text] [Related]
19. Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin.
Jakubowski JA; Maraganore JM
Blood; 1990 Jan; 75(2):399-406. PubMed ID: 2294999
[TBL] [Abstract][Full Text] [Related]
20. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
